Talaris Therapeutics Inc.

NASDAQ: TALS · Real-Time Price · USD
2.72
-0.02 (-0.73%)
At close: Oct 19, 2023, 8:00 PM

Talaris Therapeutics Revenue

Talaris Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending September 30, 2023, Talaris Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
84
Market Cap
116.44M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.